# A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

> **NCT00162448** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 36 (—)

## Conditions studied

- Heart Diseases

## Interventions

- **DRUG:** BMS-394136
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00162448
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (—)
- **Last updated:** 2008-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162448, "A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00162448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*